Search

everythinglearnresearchcommunity

for

Search:↓

Fetal death was caused by umbilical cord stricture with hair growth in the Wharton jelly.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Newborns' hair shows how much caffeine their mothers drank during pregnancy.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Zinc helps reduce the severity of depression.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Pregnancies in a woman with the Donohue mutation were managed with genetic testing, resulting in three healthy infants.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Early surgical intervention and a multidisciplinary approach are crucial for managing complex cardio-obstetric patients.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.